Rayner, Christopher K.
The University of Adelaide
27 papers on CoChatORCID 0000-0002-5527-256X
Most cited papers
- Verified
Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Diabetes Care
Gastrointestinal motility and disordersDiabetes Treatment and Management
Cited by 335
- Verified
Gastric emptying in diabetes: clinical significance and treatment
Horowitz, M., O’Donovan, D., Jones, K. L., Feinle, C., Rayner, C. K., & Samsom, M. (2002) · Diabetic Medicine
Gastrointestinal motility and disordersDiabetes Management and Research
Cited by 308
- Verified
Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes
Young, R. L., Sutherland, K., Pezos, N., Brierley, S. M., Horowitz, M., Rayner, C. K., & Blackshaw, L. A. (2009) · Gut
Biochemical Analysis and Sensing TechniquesGastrointestinal motility and disorders
Cited by 189
- Verified
Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans
Wu, T., Zhao, B. R., Bound, M. J., Checklin, H. L., Bellon, M., Little, T. J., Young, R. L., Jones, K. L., Horowitz, M., & Rayner, C. K. (2012) · The American Journal of Clinical Nutrition
Diabetes Treatment and ManagementBiochemical Analysis and Sensing Techniques
Cited by 163
- Verified
Mechanisms controlling glucose-induced GLP-1 secretion in human small intestine
Sun, E. W., de Fontgalland, D., Rabbitt, P., Hollington, P., Sposato, L., Due, S. L., Wattchow, D. A., Rayner, C. K., Deane, A. M., Young, R. L., et al. (2017) · Diabetes
Diabetes Treatment and ManagementPancreatic function and diabetes
Cited by 152
- Verified
Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2011) · Experimental Diabetes Research
Diabetes Treatment and ManagementGastrointestinal motility and disorders
Cited by 138
- Verified
Effects of ginger on gastric emptying and motility in healthy humans
Wu, K.-L., Rayner, C. K., Chuah, S.-K., Changchien, C.-S., Lu, S.-N., Chiu, Y.-C., Chiu, K.-W., & Lee, C.-M. (2008) · European Journal of Gastroenterology & Hepatology
Gastrointestinal motility and disordersGinger and Zingiberaceae research
Cited by 126
- Verified
Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes
Young, R. L., Chia, B., Isaacs, N. J., Ma, J., Khoo, J., Wu, T., Horowitz, M., & Rayner, C. K. (2013) · Diabetes
Biochemical Analysis and Sensing TechniquesDiabetes Treatment and Management
Cited by 111
- Verified
Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: Relationship to glycemia*
Deane, A. M., Chapman, M. J., Fraser, R. J. L., Summers, M. J., Zaknic, A. V., Storey, J. P., Jones, K. L., Rayner, C. K., & Horowitz, M. (2010) · Critical Care Medicine
Diabetes Treatment and ManagementClinical Nutrition and Gastroenterology
Cited by 104
- Verified
Glucagon-like peptides 1 and 2 in health and disease: A review
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Peptides
Diabetes Treatment and ManagementRegulation of Appetite and Obesity
Cited by 100
- Verified
Diabetic Gastroparesis: Diagnosis and Management
Ma, J., Rayner, C. K., Jones, K. L., & Horowitz, M. (2009) · Drugs
Gastrointestinal motility and disordersDiabetes Treatment and Management
Cited by 87
- Verified
Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control
Jalleh, R. J., Jones, K. L., Rayner, C. K., Marathe, C. S., Wu, T., & Horowitz, M. (2022) · Diabetologia
Gastrointestinal motility and disordersDiabetes Treatment and Management
Cited by 87
- Verified
Augmented capacity for peripheral serotonin release in human obesity
Young, R. L., Lumsden, A. L., Martin, A. M., Schober, G., Pezos, N., Thazhath, S. S., Isaacs, N. J., Cvijanovic, N., Sun, E. W. L., Wu, T., et al. (2018) · International Journal of Obesity
Regulation of Appetite and ObesityGastrointestinal motility and disorders
Cited by 87
- Verified
Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids
Sansome, D. J., Xie, C., Veedfald, S., Horowitz, M., Rayner, C. K., & Wu, T. (2020) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementMetabolism, Diabetes, and Cancer
Cited by 84
- Verified
The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: A randomized controlled trial
Thazhath, S. S., Marathe, C. S., Wu, T., Chang, J., Khoo, J., Kuo, P., Checklin, H. L., Bound, M. J., Rigda, R. S., Crouch, B., et al. (2016) · Diabetes
Diabetes Treatment and ManagementGastrointestinal motility and disorders
Cited by 83
- Verified
Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes
Jones, K. L., Rigda, R. S., Buttfield, M. D. M., Hatzinikolas, S., Pham, H. T., Marathe, C. S., Wu, T., Lange, K., Trahair, L. G., Rayner, C. K., et al. (2019) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 66
- Verified
New Insights Into the Anti-Diabetic Actions of Metformin: From the Liver to the Gut
Wu, T., Horowitz, M., & Rayner, C. K. (2017) · Expert Review of Gastroenterology & Hepatology
Diabetes Treatment and ManagementMetabolism, Diabetes, and Cancer
Cited by 64
- Verified
Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes
Horowitz, M., Rayner, C. K., & Jones, K. L. (2013) · Advances in Therapy
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 58
- Verified
Gut mechanisms linking intestinal sweet sensing to glycemic control
Kreuch, D., Keating, D. J., Wu, T., Horowitz, M., Rayner, C. K., & Young, R. L. (2018) · Frontiers in Endocrinology
Biochemical Analysis and Sensing TechniquesGastrointestinal motility and disorders
Cited by 40
- Verified
Gastrointestinal autonomic neuropathy in diabetes
Marathe, C. S., Jones, K. L., Wu, T., Rayner, C. K., & Horowitz, M. (2020) · Autonomic Neuroscience
Gastrointestinal motility and disordersCardiovascular Syncope and Autonomic Disorders
Cited by 38
- Verified
Prognosis of diabetic gastroparesis—a 25-year evaluation
Chang, J., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Diabetic Medicine
Gastrointestinal motility and disordersGastrointestinal Bleeding Diagnosis and Treatment
Cited by 37
- Verified
Glucagon‐like peptide‐1 receptor agonists and the appropriate measurement of gastric emptying
Horowitz, M., Rayner, C. K., Marathe, C. S., Wu, T., & Jones, K. L. (2020) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementGastrointestinal motility and disorders
Cited by 32
- Verified
Hypoglycaemia and gastric emptying
Marathe, C. S., Marathe, J. A., Rayner, C. K., Kar, P., Jones, K. L., & Horowitz, M. (2019) · Diabetes, Obesity and Metabolism
Diabetes Management and ResearchGastrointestinal motility and disorders
Cited by 32
- Verified
Effect of hyperglycemia on triggering of transient lower esophageal sphincter relaxations
Zhang, Q., Horowitz, M., Rigda, R., Rayner, C., Worynski, A., & Holloway, R. H. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology
Gastroesophageal reflux and treatmentsGastrointestinal motility and disorders
Cited by 30
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free